RegenMed Systems, Inc.
Menlo Park, California, United States
Purpose
to determine whether the MarrowMiner can be used to effectively infuse gene therapy vectors into the intraosseous space, thereby enabling in vivo gene therapies for HIV and SCD that might be brought to LMICs
Division
Global Health
Date
October 2022
Region Served
GLOBAL
Committed amount
$1,120,111
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
32
Grantee location
Menlo Park, California, United States
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.